Keros Therapeutics Inc. (KROS)
NASDAQ: KROS
· Real-Time Price · USD
14.46
0.04 (0.28%)
At close: Aug 15, 2025, 3:59 PM
14.08
-2.66%
After-hours: Aug 15, 2025, 05:42 PM EDT
Keros Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 18.77M | 4.21M | -187.35M | -181.57M | -168.05M | -160.3M | -152.99M | -142.47M | -126.54M | -116.3M | -104.68M | -81.9M | -78.69M | -67.05M | -58.74M | -62.48M | -54.22M | -49.35M |
Depreciation & Amortization | 1.36M | 1.3M | 1.23M | 1.14M | 1.04M | 925K | 815K | 695K | 611K | 728K | 674K | 651K | 628K | 411K | 378K | 349K | 318K | 295K |
Stock-Based Compensation | 35.42M | 35.66M | 34.87M | 33M | 32.89M | 31.15M | 28.76M | 26.18M | 22.23M | 19.98M | 18.68M | 17.23M | 15.56M | 13.62M | 11.72M | 9.95M | 8.29M | 6.58M |
Other Working Capital | 14.23M | 16.94M | -8.59M | -1.02M | -19.38M | -13.91M | -9.97M | -7.61M | -5.19M | -10.14M | -3.28M | -23.55M | -20.53M | -18.68M | -17.55M | 782K | 1.73M | 1.75M |
Other Non-Cash Items | 2.3M | 9.63M | 18.07M | 17.83M | 17.61M | 10.05M | 1.56M | 1.54M | 1.42M | 1.28M | 953K | 1.54M | 727K | 624K | 520K | -289K | 349K | 337K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 26K | 26K | 46K | 46K | 20K | 20K | n/a |
Change in Working Capital | -2.81M | 1.62M | -11.44M | 5.53M | -11.04M | -7.97M | -2.65M | -6.45M | -8.84M | -8.56M | 14.31M | -5.73M | 3.72M | -722K | -16.07M | 1.88M | -1.75M | 2.86M |
Operating Cash Flow | 55.04M | 44.86M | -160.87M | -140.32M | -143.8M | -134.83M | -124.51M | -120.49M | -111.11M | -102.87M | -70.06M | -68.18M | -58.02M | -53.07M | -62.15M | -50.57M | -46.99M | -39.28M |
Capital Expenditures | -1.96M | -1.55M | -1.93M | -2.18M | -2.35M | -2.35M | -2.46M | -2.27M | -1.9M | -2.16M | -1.24M | -1.05M | -1.02M | -961K | -1.02M | -925K | -810K | -328K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -1.96M | -1.55M | -1.93M | -2.18M | -2.35M | -2.35M | -2.46M | -2.27M | -1.9M | -2.16M | -1.24M | -1.05M | -1.02M | -961K | -1.02M | -925K | -810K | -328K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.32M | 6.22M | 11.69M | 9.98M | 9.38M | 8.22M | 3.13M | 2.41M | 2.22M | 983K | 731K | 961K | 900K | 455K | 379K | -279K | -305K | 99.76M |
Financial Cash Flow | 231.51M | 235.02M | 391.82M | 385.53M | 229.87M | 228.08M | 178.96M | 171.12M | 219.42M | 227.87M | 120.31M | 87.31M | 38.76M | 28.63M | 28.55M | 140.25M | 140.22M | 240.29M |
Net Cash Flow | 284.59M | 278.33M | 229.02M | 243.03M | 83.72M | 90.9M | 51.98M | 48.35M | 106.41M | 122.84M | 49.01M | 18.08M | -20.28M | -25.41M | -34.62M | 88.75M | 92.43M | 200.69M |
Free Cash Flow | 53.08M | 43.31M | -162.8M | -142.5M | -146.15M | -137.18M | -126.97M | -122.77M | -113.01M | -105.03M | -71.3M | -69.23M | -59.04M | -54.03M | -63.17M | -51.5M | -47.8M | -39.61M |